In vitro evaluation of sulfadrugs against fungi causing otomycosis

Sudhir K Jain1, S C Agrawal, P C Jain

  • 1Department of Applied Microbiology, Cancer Hospital & Research Institute, Gwalior 474 009, India. Sudhirkjain1@rediffmail.com

Hindustan Antibiotics Bulletin
|April 6, 2004
PubMed

Insights

Sulfamethoxazole demonstrated the highest antifungal efficacy, inhibiting mycelial growth by up to 96.78% in pathogenic fungi. Increasing sulfadrug concentrations gradually reduced fungal growth and sporulation.

Area of Science:

  • Mycology
  • Antimicrobial drug efficacy

Background:

  • Pathogenic fungi pose significant threats to agriculture and human health.
  • Sulfadrugs are a class of antimicrobial agents with potential antifungal properties.

Purpose of the Study:

  • To evaluate the efficacy of four sulfadrugs against five pathogenic fungi.
  • To determine the optimal sulfadrug and dosage for controlling fungal growth and sporulation.

Main Methods:

  • Four sulfadrugs (sulfadiazine, sulfamethoxazole, sulfaguanidine, sulfamoxole) were tested.
  • Different concentrations (500-2500 ppm) were applied to inhibit mycelial growth and sporulation.
  • The study assessed inhibition percentages against fungi like P. nigricans, A. flavus, A. corymbifera, A. niger, and C. albicans.

Main Results:

  • Sulfamethoxazole was the most effective, showing up to 96.78% inhibition of mycelial growth at 2500 ppm.
  • Sulfadiazine inhibited A. niger by 77.26%, and sulfaguanidine inhibited A. corymbifera by 56.39% at 2500 ppm.
  • All tested sulfadrugs showed a dose-dependent inhibitory effect on fungal growth and sporulation.

Conclusions:

  • Sulfamethoxazole exhibits potent antifungal activity against a range of pathogenic fungi.
  • Sulfadrugs offer a viable strategy for controlling fungal infections, with efficacy varying by drug and fungal species.